https://hepquant.com/news-events/hepquant-lab-moves-to-new-location-within-fitzsimons-innovation-community-campus/ 2023-07-27T21:03:00+00:00 https://hepquant.com/wp-content/uploads/2023/07/HepQuant-Lab-at-Bioscience-Building-2023.jpeg https://hepquant.com/wp-content/uploads/2023/07/hepquant-test-lab-space.jpeg https://hepquant.com/news-events/hepquant-names-clinical-accounts-manager-lab-operations-manager/ 2023-08-01T22:43:03+00:00 https://hepquant.com/news-events/dr-steve-helmke-appointed-chief-scientific-officer/ 2023-08-01T22:44:39+00:00 https://hepquant.com/news-events/hepquant-announces-approval-of-3rd-ide/ 2023-08-01T22:46:16+00:00 https://hepquant.com/news-events/hepquant-announces-approval-of-2nd-ide/ 2023-08-02T15:14:31+00:00 https://hepquant.com/news-events/hepquant-announces-approval-of-1st-ide/ 2023-08-02T15:15:43+00:00 https://hepquant.com/news-events/hepquant-announces-additions-to-the-executive-leadership-team-to-drive-commercialization/ 2023-08-02T16:33:05+00:00 https://hepquant.com/news-events/hepion-pharmaceuticals-phase-2-altitude-nash-trial-achieves-primary-and-secondary-endpoints-including-improvement-in-liver-function-and-multiple-nash-biomarkers/ 2023-08-03T18:34:36+00:00 https://hepquant.com/news-events/hepion-pharma-announces-first-dosing-in-phase-2b-clinical-trial-with-hepquant-endpoints/ 2023-08-03T18:35:18+00:00 https://hepquant.com/news-events/hepion-pharmaceuticals-announces-clinical-collaboration-with-hepquant-in-phase-2b-nash-trial/ 2023-08-03T18:35:22+00:00 https://hepquant.com/news-events/hepion-pharmaceuticals-announces-early-completion-of-enrollment-in-phase-2-altitude-nash-liver-function-trial-2/ 2023-08-03T18:35:28+00:00 https://hepquant.com/news-events/preliminary-data-from-the-hepquant-shunt-v-pivotal-study-released-during-the-72nd-aasld-annual-meeting/ 2023-08-03T23:03:34+00:00 https://hepquant.com/news-events/perspectum-and-hepquant-announce-partnership-to-bring-a-more-complete-picture-of-liver-health/ 2023-08-03T23:06:34+00:00 https://hepquant.com/wp-content/uploads/2023/08/HepQuant-Perspectume-logo-image.jpg https://hepquant.com/news-events/hepquants-greg-everson-md-to-speak-at-aasld-fda-conference-on-drug-induced-liver-injury-dili/ 2023-08-03T23:08:16+00:00 https://hepquant.com/news-events/hepquant-promotes-sean-bundy-to-chief-operating-officer/ 2023-08-03T23:11:05+00:00 https://hepquant.com/wp-content/uploads/2023/08/Shawn-Bundy-225X300.png https://hepquant.com/news-events/hepquant-to-offer-mobile-and-remote-test-administration-via-cvs-healths-coram-clinical-trials/ 2023-08-03T23:11:48+00:00 https://hepquant.com/news-events/hepquant-to-present-at-biotech-showcase-2020/ 2023-08-03T23:13:04+00:00 https://hepquant.com/news-events/hepquants-disease-severity-index-dsi-demonstrates-hepatic-functional-improvement-in-high-percentage-of-nash-patients-treated-with-obeticholic-acid-results-from-intercept-747-117/ 2023-08-03T23:14:21+00:00 https://hepquant.com/news-events/hoffman-joins-hepquant-as-clinical-lab-manager/ 2023-08-03T23:15:27+00:00 https://hepquant.com/wp-content/uploads/2023/08/Keith-Hoffman-Feb-2019b.jpg https://hepquant.com/news-events/first-patient-enrolled-in-a-pivotal-trial-of-the-hepquant-shunt-liver-diagnostic-test/ 2023-08-03T23:16:25+00:00 https://hepquant.com/news-events/sarah-downing-joins-hepquant-as-senior-manager-of-quality-affairs/ 2023-08-03T23:17:23+00:00 https://hepquant.com/wp-content/uploads/2023/08/sarah-downing.png https://hepquant.com/news-events/receives-ide-approval-from-u-s-fda-to-initiate-clinical-trial-of-the-shunt-liver-diagnostic-kit/ 2023-08-03T23:19:31+00:00 https://hepquant.com/news-events/sean-bundy-appointed-director-of-regulatory-and-quality-affairs/ 2023-08-03T23:20:58+00:00 https://hepquant.com/wp-content/uploads/2023/08/Shawn-Bundy-225X300.png https://hepquant.com/news-events/hepquant-chosen-to-advance-to-innostars-semifinals-in-china/ 2023-08-03T23:21:49+00:00 https://hepquant.com/news-events/hepquant-a-finalist-for-innostars-denver-competition/ 2023-08-03T23:22:34+00:00 https://hepquant.com/news-events/hepquant-and-cti-clinical-trial-and-consulting-services-announce-first-patient-enrolled-in-liver-disease-diagnostic-trial/ 2023-08-03T23:23:42+00:00 https://hepquant.com/news-events/hepquant-to-present-poster-as-finalist-at-resi-san-francisco-innovation-challenge/ 2023-08-03T23:24:23+00:00 https://hepquant.com/news-events/hepquant-to-present-at-the-10th-annual-biotech-showcase/ 2023-08-03T23:25:19+00:00 https://hepquant.com/news-events/hepquant-presents-at-rocky-mountain-life-science-investor-and-partnering-conference/ 2023-08-03T23:26:02+00:00 https://hepquant.com/news-events/hepquant-holding-its-2017-scientific-advisory-board-meeting-in-washington-d-c-on-saturday-october-21st/ 2023-08-03T23:26:35+00:00 https://hepquant.com/news-events/hepquant-to-sponsor-its-first-clinical-study/ 2023-08-03T23:27:15+00:00 https://hepquant.com/news-events/hepquant-announces-approval-of-4th-ide/ 2023-08-03T23:27:55+00:00 https://hepquant.com/news-events/hepquant-completes-third-state-sponsored-grant/ 2023-08-03T23:28:27+00:00 https://hepquant.com/news-events/test-inventor-and-founder-dr-everson-accepts-role-as-ceo/ 2023-08-03T23:28:51+00:00 https://hepquant.com/news-events/preliminary-data-from-the-hepquant-shunt-v-pivotal-study-presented-at-ddw-2022/ 2023-08-14T22:16:05+00:00 https://hepquant.com/news-events/pharma-and-medical-device-veteran-ally-xu-named-director-of-regulatory-and-quality-affairs/ 2023-08-14T22:17:14+00:00 https://hepquant.com/wp-content/uploads/2023/07/a-xu-sm-li.jpeg https://hepquant.com/news-events/chris-jensen-joins-business-advisory-board/ 2023-08-14T22:28:20+00:00 https://hepquant.com/wp-content/uploads/2022/05/c-jensen-sm-pr.png https://hepquant.com/news-events/bobbi-coffin-named-to-business-advisory-board/ 2023-08-14T22:29:16+00:00 https://hepquant.com/wp-content/uploads/2022/05/b-coffin-sm-pr.png https://hepquant.com/news-events/hepquant-lab-meets-cola-clia-quality-standards/ 2023-08-14T22:30:45+00:00 https://hepquant.com/wp-content/uploads/2022/08/accreditation_seal_cola.png https://hepquant.com/news-events/hepquant-appoints-kelly-r-pitts-ph-d-chief-operating-officer/ 2023-08-15T15:42:44+00:00 https://hepquant.com/wp-content/uploads/2023/04/Kelly-Pitts-apr-2023.jpg https://hepquant.com/news-events/aasld-the-liver-meeting/ 2023-10-14T00:41:48+00:00 https://hepquant.com/wp-content/uploads/2023/06/TLM2023_Base-Logo-with-Date_8.10.22_CMYK.png https://hepquant.com/news-events/aasld-the-liver-meeting-2024/ 2024-11-05T16:02:03+00:00 https://hepquant.com/wp-content/uploads/2024/08/aasld-2024.png https://hepquant.com/news-events/5th-annual-liver-connect-conference/ 2025-03-17T14:09:10+00:00 https://hepquant.com/news-events/global-hepatitis-summit-2025/ 2025-03-17T14:09:45+00:00 https://hepquant.com/news-events/hepquant-celebrates-lab-week-2025/ 2025-04-24T19:38:16+00:00 https://hepquant.com/news-events/hepquant-to-present-at-key-liver-conferences-to-highlight-applications-of-hepquant-duo-a-quantitative-liver-health-test/ 2025-04-24T21:33:16+00:00 https://hepquant.com/news-events/hepquant-introduces-hepquant-duo-a-quantitative-liver-function-test-for-patients-with-liver-disease-with-6-presented-abstracts-at-the-liver-meeting-2024/ 2025-04-25T20:05:03+00:00 https://hepquant.com/news-events/hepquant-appoints-kelly-r-pitts-ph-d-chief-operating-officer-copy/ 2025-04-28T15:33:02+00:00 https://hepquant.com/news-events/hepquant-named-one-of-colorados-best-health-diagnostics-companies/ 2025-04-28T15:36:35+00:00 https://hepquant.com/news-events/as-it-awaits-key-readout-hepion-boosts-confidence-in-nash-drug-hopeful-via-shorter-study/ 2025-04-28T15:38:28+00:00 https://hepquant.com/news-events/hepion-pharma-announces-first-dosing-in-phase-2b-clinical-trial-with-hepquant/ 2025-04-28T15:39:43+00:00 https://hepquant.com/news-events/tackling-liver-disease-with-a-multimodal-cyclophilin-inhibitor/ 2025-04-28T15:41:11+00:00 https://hepquant.com/news-events/statins-show-promise-for-advanced-liver-failure-and-cirrhosis/ 2025-04-28T15:41:45+00:00 https://hepquant.com/news-events/hepquant-to-present-quantification-of-human-and-porcine-liver-function-in-an-extracorporeal-liver-circuit-elc-at-the-ddw-2025-late-breaking-plenary-session/ 2025-05-09T22:16:08+00:00 https://hepquant.com/news-events/hepquant-demonstrates-new-advancements-in-management-of-patients-with-acute-liver-failure-dependent-on-extracorporeal-liver-cross-circulation-elc/ 2025-05-12T15:24:12+00:00 https://hepquant.com/wp-content/uploads/2025/05/MM_Press-Release-Figure.png https://hepquant.com/wp-content/uploads/2025/05/MM_Press-Release-Figure.png https://hepquant.com/news-events/hepquant-achieves-iso-13485-certification-to-support-scaling-of-hepquant-duo-to-global-clinical-trials/ 2025-06-02T14:15:15+00:00 https://hepquant.com/news-events/namcps-spring-managed-care-forum/ 2025-07-17T16:37:09+00:00 https://hepquant.com/news-events/ddw-2025/ 2025-07-17T16:41:06+00:00 https://hepquant.com/news-events/2025-texas-society-of-gastroenterology-and-endoscopy-annual-meeting/ 2025-07-17T16:44:38+00:00 https://hepquant.com/news-events/ghapp-eighth-annual-conference/ 2025-07-17T17:36:14+00:00 https://hepquant.com/news-events/easl-congress-2025/ 2025-07-17T19:04:30+00:00 https://hepquant.com/news-events/emerging-topics-in-liver-disease/ 2025-09-02T15:53:08+00:00 https://hepquant.com/news-events/paris-liver-forum-paris-mash/ 2025-09-02T16:00:09+00:00 https://hepquant.com/news-events/9th-mash-drug-development-summit-2025/ 2025-09-02T19:16:18+00:00 https://hepquant.com/news-events/hepquant-duo-estimates-risk-for-clinical-outcome-and-quantifies-changes-in-risk/ 2025-09-17T22:36:04+00:00 https://hepquant.com/news-events/doing-it-in-the-desert-viral-hepatitis-sti-elimination-summit/ 2025-09-24T22:51:52+00:00 https://hepquant.com/news-events/the-liver-meeting/ 2025-09-24T22:56:58+00:00 https://hepquant.com/news-events/hepquant-presents-a-new-application-for-the-hepquant-duo-test-improved-study-design-and-treatment-monitoring-in-clinical-trials/ 2025-10-02T13:59:14+00:00 https://hepquant.com/news-events/hepquant-announces-exciting-new-data-utilizing-hepquant-duo-testing-early-assessment-of-resmetirom-treatment-benefit-in-patients-with-compensated-mash-cirrhosis/ 2025-10-14T18:25:32+00:00 https://hepquant.com/news-events/2667/ 2025-11-06T15:15:17+00:00 https://hepquant.com/news-events/dr-greg-everson-speaks-at-psc-forum-9-in-washington-dc/ 2025-11-14T20:14:08+00:00 https://hepquant.com/news-events/southern-california-society-of-gastroenterology-liver-symposium/ 2025-11-21T16:02:25+00:00 https://hepquant.com/news-events/2026-mash-tag-oral-presentation-hepquant-duo-reveals-functional-and-physiological-heterogeneity-to-support-enhanced-clinical-trial-design/ 2026-01-12T19:17:09+00:00 https://hepquant.com/news-events/transplanting-hope-the-intersection-of-liver-transplantation-and-alcohol-use-disorder-exhibit-registration/ 2026-03-11T22:21:54+00:00 https://hepquant.com/news-events/ddw-2026/ 2026-03-25T20:13:26+00:00 https://hepquant.com/news-events/easl-congress-2026/ 2026-03-25T20:15:20+00:00 https://hepquant.com/news-events/donor-dash-2026/ 2026-03-25T20:16:44+00:00 https://hepquant.com/news-events/fueling-mash-metabolic-drivers-and-inflammatory-crosstalk/ 2026-04-02T16:21:55+00:00 https://hepquant.com/news-events/2026-ddw-oral-presentation-hepquant-duo-disease-severity-index-dsi-outperforms-child-pugh-and-meld-scores-in-predicting-risk-of-esophageal-varices/ 2026-05-05T13:47:17+00:00 https://hepquant.com/news-events/ghaap-regional-conference-hot-topics-in-chronic-liver-disease/ 2026-05-05T13:51:07+00:00 https://hepquant.com/news-events/ghaap-regional-conference-hot-topics-in-chronic-liver-disease-and-gi-disorders/ 2026-05-05T13:53:08+00:00 https://hepquant.com/news-events/three-presentations-at-easl-2026-highlight-the-clinical-and-drug-development-value-of-hepquant-duo/ 2026-05-27T13:49:43+00:00 https://hepquant.com/news-events/hepquant-achieves-college-of-american-pathologists-cap-accreditation-demonstrating-commitment-to-laboratory-excellence/ 2026-06-08T14:08:54+00:00 https://hepquant.com/news-events/hepquant-sponsors-team-at-the-transplant-games-of-america/ 2026-06-15T22:10:33+00:00 https://hepquant.com/news-events/fda-approves-the-hepquant-shunt-liver-diagnostic-test-to-quantify-risk-of-large-esophageal-varices-in-adult-patients-with-compensated-cirrhosis-child-pugh-class-a/ 2026-06-23T13:41:46+00:00 https://hepquant.com/news-events/hepquant-duo-study-named-a-journal-of-clinical-medicine-editors-choice-article/ 2026-08-12T15:09:37+00:00